XNAS
GYRO
Market cap10mUSD
Oct 08, Last price
4.70USD
1D
0.00%
1Q
-24.56%
Jan 2017
-74.22%
IPO
-84.55%
Name
Gyrodyne LLC
Chart & performance
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
0
Net income
0
CFO
0
Dividend
Jun 23, 20171 USD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Gyrodyne, LLC is a real estate firm engaged in the acquisition, leasing, and oversight of various commercial properties. A core principle of their business model is a strong commitment to customer service across all aspects of their property holdings and management activities. While historically operating primarily in Long Island, Gyrodyne has substantially expanded its footprint, now managing a diverse portfolio spanning the entire East Coast, with a notable specialization in medical office spaces.
Key people
Gary Fitlin
President, Chief Executive Officer, Chief Financial Officer, Treasurer · since 2017
Peter Pitsiokos
Chief Operating Officer, Executive Vice President, Chief Compliance Officer, Company Secretary · since 2004
Paul Lamb
Independent Non-Executive Chairman of the Board · since 1999
Independent Director · since 2023
Ronald Macklin
Independent Director · since 2003
Nader Salour
Independent Director · since 2006
Richard Smith
Independent Director · since 2002
Legal address
ONE FLOWERFIELD
SUITE 24
SAINT JAMES, NY 11780
US
SUITE 24
SAINT JAMES, NY 11780
US
Headquarters
1 Flowerfield
Suite 24
St. James, NY 11780
US
Suite 24
St. James, NY 11780
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||